| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
1,729.95
|
|
Change (%)
|
-31.50 (-1.79%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
1,727.15
-
1,762.00
|
|
52-Week Range (RS)
|
1,547.25
-
1,850.95
|
|
Beta (1 Year)
|
0.73
|
|
|
|
|
|
| Index Details |
| BSE SENSEX, BSE 100, BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE GREENEX, bse carbonex |
| News |
|
Corporate Details |
| Sun Pharmaceutical Industries Ltd spurts 0.05%, gains for five straight sessions |
| Sun Pharmaceutical Industries Ltd eases for fifth straight session |
| USFDA classifies Sun Pharma's Baska facility inspection as Official Action Indicated |
| Sun Pharma declines after US FDA classifies Baska facility inspection as OAI |
| Sun Pharma launches innovative drug ILUMYA (Tildrakizumab) in India |
| Astrazeneca Pharma and Sun Pharma form second brand partnership |
| Sun Pharmaceutical Industries Ltd up for fifth session |
| Sun Pharma records PAT of Rs 3,118 crore in Q3 |
| Sun Pharmaceutical Industries Ltd - Sun Pharmaceutical Industries Limited - Copy of Newspaper Publication |
| Sun Pharmaceutical Industries consolidated net profit rises 2.56% in the September 2025 quarter |
|
|
|
| Incoporation Year : 1993 |
| Chairman : Dilip S Shanghvi |
| Ownership Group : Sun Pharma |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Sun Pharmaceutical Industries Ltd
Sun Pharma Advanced Res.Centre,
Tandalja,
Vadodara,
Gujarat-390020 |
Phone:91-265-6615500
Fax:91-265-2354897 |
| E-Mail : secretarial@sunpharma.com |
| URL : http://www.sunpharma.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
01-Jan-2026 |
1720.40 |
2.39 |
| 1Month |
08-Dec-2025 |
1795.30 |
-1.89 |
| 3Month |
08-Oct-2025 |
1631.65 |
7.96 |
| 6Month |
08-Jul-2025 |
1672.85 |
5.30 |
| 1Year |
08-Jan-2025 |
1837.30 |
-4.13 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| SBI Nifty 50 ETF |
1.62 |
3515.20 |
| ICICI Pru Value Fund |
4.57 |
2802.85 |
| SBI BSE SENSEX ETF |
1.92 |
2420.54 |
| ICICI Pru Equity & Debt Fund |
4.70 |
2332.10 |
| ICICI Pru Large Cap Fund |
2.61 |
2052.06 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Cipla Ltd |
1,466.15 |
0.38 |
1,672.20 |
1,310.05 |
118,431.38 |
| Dr Reddys Laboratories Ltd |
1,209.45 |
0.16 |
1,385.00 |
1,025.90 |
100,944.37 |
| Lupin Ltd |
2,181.45 |
-0.41 |
2,292.90 |
1,774.00 |
99,648.38 |
| Mankind Pharma Ltd |
2,199.75 |
-2.52 |
2,882.45 |
2,090.10 |
90,806.80 |
| Zydus Lifesciences Ltd |
894.95 |
-1.39 |
1,059.00 |
797.05 |
90,052.91 |
|
|
|
|